» Articles » PMID: 25433419

A Retrospective Statistical Analysis of the Late Complications Associated with Central Venous Port Placements

Overview
Journal Jpn J Radiol
Publisher Springer
Specialty Radiology
Date 2014 Dec 1
PMID 25433419
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Central venous (CV) ports are being used increasingly in both hospital and home care settings. Here, we investigated the rates and causes of CV port complications.

Materials And Methods: We retrospectively analyzed the placement of 264 consecutive CV ports in 239 consecutive patients admitted to our hospital between September 2009 and February 2012. All CV ports were inserted under fluoroscopy and ultrasound visualization by interventional radiologists using maximum barrier precautions. CV port complications were checked in detail and analyzed statistically.

Results: Total indwelling time for all CV ports was 51,033 catheter days. Of the 264 CV ports assessed, 50 were removed during the study period because of any complication and 147 remained at the end of the study period. In 33 cases, the patient died before the end of the study. Of the 50 patients who underwent CV port removal, 13 were diagnosed as having catheter-related bloodstream infection (CRBSI). The total rate of CV port removal because of any complication was 0.98 cases per 1,000 catheter days, that of catheter troubles was 0.22 cases per 1,000 catheter days and that of CRBSI was 0.25 cases per 1,000 catheter days. Steroid administration and total parenteral nutrition (TPN) were associated with increased rates of infection. It seems that chemotherapy and indwelling time were also considered important factors.

Conclusion: Steroid administration and TPN were associated with increased rates of infection. In addition, patients receiving chemotherapy or whose CV ports are left in place for a long time should be carefully observed to decrease these complications.

Citing Articles

Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis.

Suzuki T, Michimoto K, Hasumi J, Kisaki S, Hasegawa Y, Fujimori A Cardiovasc Intervent Radiol. 2023; 46(12):1696-1702.

PMID: 37902854 PMC: 10695883. DOI: 10.1007/s00270-023-03583-y.


A Retrospective Analysis of Venographic Images of a Central Venous Port without Blood Return and Its Usable Period.

Yagi T, Maeda N, Nakanishi K Intern Med. 2023; 62(19):2827-2831.

PMID: 36823086 PMC: 10602839. DOI: 10.2169/internalmedicine.1249-22.


Standardized procedure prevents perioperative and early complications in totally implantable venous-access ports-a complication analysis of more than 1000 TIVAP implantations.

Thiel K, Kalmbach S, Maier G, Wichmann D, Schenk M, Konigsrainer A Langenbecks Arch Surg. 2022; 407(8):3755-3762.

PMID: 36070032 PMC: 9722872. DOI: 10.1007/s00423-022-02656-9.


Effectiveness of a flow confirmation study of a central venous port of the upper arm versus the chest wall in patients with suspected system-related mechanical complications.

Tokue H, Tokue A, Tsushima Y World J Surg Oncol. 2022; 20(1):91.

PMID: 35317828 PMC: 8939116. DOI: 10.1186/s12957-022-02565-7.


Outcomes following port-a-catheter placement in the Medicare population.

Khalid S, Maasarani S, Shanker R, Wiegmann A, Wu R, Skertich N Surg Open Sci. 2021; 3:39-43.

PMID: 33937739 PMC: 8077681. DOI: 10.1016/j.sopen.2020.10.002.


References
1.
OGrady N, Alexander M, Dellinger E, Gerberding J, Heard S, Maki D . Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002; 51(RR-10):1-29. View

2.
Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A . Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998; 9(7):767-73. DOI: 10.1023/a:1008392423469. View

3.
Vardy J, Engelhardt K, Cox K, Jacquet J, McDade A, Boyer M . Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer. 2004; 91(6):1045-9. PMC: 2747721. DOI: 10.1038/sj.bjc.6602082. View

4.
Gebauer B, El-Sheik M, Vogt M, Wagner H . Combined ultrasound and fluoroscopy guided port catheter implantation--high success and low complication rate. Eur J Radiol. 2009; 69(3):517-22. DOI: 10.1016/j.ejrad.2007.10.018. View

5.
Torramade J, A Cienfuegos J, Hernandez J, Pardo F, Benito C, Gonzalez J . The complications of central venous access systems: a study of 218 patients. Eur J Surg. 1993; 159(6-7):323-7. View